Comprehensive Histologic Analysis of ALK-Rearranged Lung Carcinomas

被引:263
作者
Yoshida, Akihiko [4 ]
Tsuta, Koji
Nakamura, Harumi
Kohno, Takashi [5 ]
Takahashi, Fumiaki [7 ]
Asamura, Hisao [2 ]
Sekine, Ikuo [3 ]
Fukayama, Masashi [4 ]
Shibata, Tatsuhiro [6 ]
Furuta, Koh
Tsuda, Hitoshi [1 ]
机构
[1] Natl Canc Ctr, Pathol & Clin Lab Div, Chuo Ku, Tokyo 1040045, Japan
[2] Natl Canc Ctr, Div Thorac Surg, Tokyo 1040045, Japan
[3] Natl Canc Ctr, Div Thorac Oncol, Tokyo 1040045, Japan
[4] Univ Tokyo, Dept Pathol, Tokyo, Japan
[5] Natl Canc Ctr, Res Inst, Div Genome Biol, Ctr Med Genom, Tokyo 104, Japan
[6] Natl Canc Ctr, Res Inst, Div Canc Genom, Ctr Med Genom, Tokyo 104, Japan
[7] Kitasato Univ, Sch Pharm, Dept Clin Med Biostat, Tokyo, Japan
关键词
adenocarcinoma; EML4-ALK; histomorphology; lung; EML4-ALK FUSION; GENE-EXPRESSION; EGFR MUTATIONS; ADENOCARCINOMA; CANCER; RECLASSIFICATION; GEFITINIB; SUBSET; TUMORS;
D O I
10.1097/PAS.0b013e3182233e06
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
A subset (1% to 5%) of non-small-cell lung carcinomas harbors the EML4-ALK fusion gene. Data from previous studies on the histomorphology of ALK-rearranged lung cancer are inconsistent, and the specific histologic parameters that characterize this subset and how accurately such parameters predict underlying ALK abnormality remain uncertain. To answer these questions, we performed a comprehensive histologic analysis of 54 surgically resected, extensively sampled ALK-rearranged lung carcinomas and compared them with 100 consecutive resections of ALK-wild-type lung cancers. All 54 cases showed at least a focal adenocarcinoma component, and 3 and 2 cases had additional squamous and sarcomatoid differentiation, respectively. Solid or acinar growth pattern, cribriform structure, presence of mucous cells (signet-ring cells or goblet cells), abundant extracellular mucus, lack of lepidic growth, and lack of significant nuclear pleomorphism were more common in ALK-positive cancers. Two recognizable constellations of findings, a solid signet-ring cell pattern and a mucinous cribriform pattern, were present at least focally in the majority (78%) of ALK-positive tumors, but were rare (1%) in ALK-negative tumors. Multivariate analysis showed that a combination of these 2 patterns was the most powerful histologic indicator of ALK rearrangement. Characteristic histologies were present both in primary sites and in metastases. Thus, histologic findings may help to identify cases for ALK testing. However, none of the histologic parameters were completely sensitive or specific to ALK rearrangement, and histomorphology should not replace confirmatory molecular or immunohistochemical studies. ALK-positive cancers commonly showed coexpression of thyroid transcription factor-1 and p63, and its significance is currently unclear.
引用
收藏
页码:1226 / 1234
页数:9
相关论文
共 25 条
[11]  
2-#
[12]   EGFR mutations in lung cancer:: Correlation with clinical response to gefitinib therapy [J].
Paez, JG ;
Jänne, PA ;
Lee, JC ;
Tracy, S ;
Greulich, H ;
Gabriel, S ;
Herman, P ;
Kaye, FJ ;
Lindeman, N ;
Boggon, TJ ;
Naoki, K ;
Sasaki, H ;
Fujii, Y ;
Eck, MJ ;
Sellers, WR ;
Johnson, BE ;
Meyerson, M .
SCIENCE, 2004, 304 (5676) :1497-1500
[13]   EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib [J].
Pao, W ;
Miller, V ;
Zakowski, M ;
Doherty, J ;
Politi, K ;
Sarkaria, I ;
Singh, B ;
Heelan, R ;
Rusch, V ;
Fulton, L ;
Mardis, E ;
Kupfer, D ;
Wilson, R ;
Kris, M ;
Varmus, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (36) :13306-13311
[14]   Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond [J].
Pencina, Michael J. ;
D'Agostino, Ralph B., Sr. ;
D'Agostino, Ralph B., Jr. ;
Vasan, Ramachandran S. .
STATISTICS IN MEDICINE, 2008, 27 (02) :157-172
[15]   Comments on 'Integrated discrimination and net reclassification improvements - Practical advice' [J].
Pencina, Michael J. ;
D'Agostino, Ralph B., Sr. ;
D'Agostino, Ralph B., Jr. ;
Vasan, Ramachandra S. .
STATISTICS IN MEDICINE, 2008, 27 (02) :207-212
[16]   Unique Clinicopathologic Features Characterize ALK-Rearranged Lung Adenocarcinoma in the Western Population [J].
Rodig, Scott J. ;
Mino-Kenudson, Mari ;
Dacic, Sanja ;
Yeap, Beow Y. ;
Shaw, Alice ;
Barletta, Justine A. ;
Stubbs, Hannah ;
Law, Kenny ;
Lindeman, Neal ;
Mark, Eugene ;
Janne, Pasi A. ;
Lynch, Thomas ;
Johnson, Bruce E. ;
Iafrate, A. John ;
Chirieac, Lucian R. .
CLINICAL CANCER RESEARCH, 2009, 15 (16) :5216-5223
[17]   ANAPLASTIC LARGE-CELL LYMPHOMAS EXPRESSING THE NOVEL CHIMERIC PROTEIN P80(NPM/ALK) - A DISTINCT CLINICOPATHOLOGICAL ENTITY [J].
SHIOTA, M ;
NAKAMURA, S ;
ICHINOHASAMA, R ;
ABE, M ;
AKAGI, T ;
TAKESHITA, M ;
MORI, N ;
FUJIMOTO, J ;
MIYAUCHI, J ;
MIKATA, A ;
NANBA, K ;
TAKAMI, T ;
YAMABE, H ;
TAKANO, Y ;
IZUMO, T ;
NAGATANI, T ;
MOHRI, N ;
NASU, K ;
SATOH, H ;
KATANO, H ;
FUJIMOTO, J ;
YAMAMOTO, T ;
MORI, S .
BLOOD, 1995, 86 (05) :1954-1960
[18]  
Sobin LH., 2002, International Union Against Cancer (UICC), V6th
[19]   Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer [J].
Soda, Manabu ;
Choi, Young Lim ;
Enomoto, Munehiro ;
Takada, Shuji ;
Yamashita, Yoshihiro ;
Ishikawa, Shunpei ;
Fujiwara, Shin-ichiro ;
Watanabe, Hideki ;
Kurashina, Kentaro ;
Hatanaka, Hisashi ;
Bando, Masashi ;
Ohno, Shoji ;
Ishikawa, Yuichi ;
Aburatani, Hiroyuki ;
Niki, Toshiro ;
Sohara, Yasunori ;
Sugiyama, Yukihiko ;
Mano, Hiroyuki .
NATURE, 2007, 448 (7153) :561-U3
[20]   KIF5B-ALK, a Novel Fusion Oncokinase Identified by an Immunohistochemistry-based Diagnostic System for ALK-positive Lung Cancer [J].
Takeuchi, Kengo ;
Choi, Young Lim ;
Togashi, Yuki ;
Soda, Manabu ;
Hatano, Satoko ;
Inamura, Kentaro ;
Takada, Shuji ;
Ueno, Toshihide ;
Yamashita, Yoshihiro ;
Satoh, Yukitoshi ;
Okumura, Sakae ;
Nakagawa, Ken ;
Ishikawa, Yuichi ;
Mano, Hiroyuki .
CLINICAL CANCER RESEARCH, 2009, 15 (09) :3143-3149